Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: Changes in caffeine metabolite ratios in response to controlled vegetable diets

Carcinogenesis

Volumn 21, Issue 6, 2000, Pages 1157-1162

  Lampe, Johanna W ^a   King, Irena B ^a   Li, Sue ^a   Grate, Margaret T ^a   Barale, Karen V ^a   Chen, Chu ^a   Feng, Ziding ^a   Potter, John D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CAFFEINE; PHENACETIN O DEETHYLASE; XANTHINE OXIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; FEMALE; FOOD INTAKE; GENDER; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; URINALYSIS; URINE VOLUME; VEGETABLE;

EID: 0034051263     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.6.1157     Document Type: Article

References (50)

1. Vermeulen, N.P.E. (1996) Role of metabolism in chemical toxicity. In Ioannides, C. (ed.) Cytochromes P450: Metabolic and Toxicological Aspects. CRC Press, Boca Raton, FL. pp. 29-53.
2. Rojas, M., Alexandrov, K., Cascorbi, I., Brockmöller, J., Likhachev, A., Pozharisski, K., Bouvier, G., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I. and Bartsch, H. (1998) High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics, 8, 109-118.
3. Mollerup, S., Ryberg, D., Hewer, A., Phillips, D.H. and Haugen, A. (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res., 59, 3317-3320.
4. Boobis, A.R., Lynch, A.M., Murray, S., de la Torre, R., Solans, A., Farre, M., Segura, J., Gooderham, N.J. and Davies, D.S. (1994) CYPIA2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is the major route of metabolism in humans. Cancer Res., 54, 89-94.
5. Guengerich, F.P., Shimada, T., Yun, C.H., Yamazaki, H., Raney, K.D., Thier, R., Coles, B. and Harris, T.M. (1994) Interactions of ingested food, beverage and tobacco components involving human cytochrome P4501A2, 2A6, 2E1 and 3A4 enzymes. Environ. Health Perspect., 102 (suppl. 9), 49-53.
6. 1. Cancer Res., 54, 101-108.
7. Kalow, W. and Tang, B.K. (1991) Caffeine as a metabolic probe: exploration of the enzyme inducing effect of cigarette smoking. Clin. Pharmacol. Ther., 49, 44-48.
8. Butler, M.A., Lang, N.P., Young, J.F. Caporaso, N.E., Vineis, P., Hayes, R.B., Teitel, C.H., Massengill, J.P., Lawsen, M.F. and Kadlubar, F.F. (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics, 2, 116-127.
9. Vistisen, K., Poulsen, H.E. and Loft, S. (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis, 13, 1561-1568.
10. Kall, M.A., Vang, O. and Clausen, J. (1996) Effects of dietary broccoli on human in vivo drug metabolising enzymes: evaluation of caffeine, estrone and chlozoxazone metabolism. Carcinogenesis, 17, 793-799.
11. Sinha, R., Rothman, N., Brown, E.D., Mark, S.D., Hoover, R.N., Caporaso, N.E., Levander, O.A., Knize, M.G., Lang, N.P. and Kadlubar, F.F. (1994) Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans. Cancer Res., 54, 6154-6159.
12. Fuhr, U., Klittich, K. and Staib, A.H. (1993) Inhibitory effect of grapefruit juice and the active component naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol., 35, 431-436.
13. Le Marchand, L., Franke, A.A., Custer, L., Wilkens, L.R. and Cooney, R.V. (1997) Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics, 7, 11-19.
14. Tantcheva-Po'r, I., Zaigler, M., Rietbrock, S. and Fuhr, U. (1999) Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics, 9, 131-144.
15. Probst-Hensch, N.M., Tannenbaum, S.R., Chan, K.K., Coetzee, G.A., Ross, R.K. and Yu, M.C. (1998) Absence of the glutathione S-transferase M1 gene increases cytochrome P450 1A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population. Cancer Epidemiol. Biomarkers Prev., 7, 635-638.
16. Seow, A., Shi, C.-Y., Chung, F.-L., Jiao, D., Hankin, J.H., Lee, H.-P., Coetzee, G.A. and Yu, M.C. (1998) Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/ P1 genotypes. Cancer Epidemiol. Biomarkers Prev., 7, 775-781.
17. Le Marchand, L., Sivaraman, L., Franke, A.A., Custer, L.J., Wilkens, L.R., Lau, A.F. and Cooney, R.V. (1996) Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies? Cancer Epidemiol. Biomarkers Prev., 5, 449-455.
18. Gross, M., Kruisselbrink, T., Anderson, K., Lang, N., McGovern, P., Delongchamp, R. and Kadlubar, F. (1999) Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol. Biomarkers Prev., 8, 683-692.
19. Hengstler, J.G., Arand, M., Herrero, M.E. and Oesch, F. (1998) Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res., 154, 47-85.
20. Kashuba, A.D.M., Bertino, J.S., Kearns, G.L., Leeder, J.S., James, A.W., Gotschall, R. and Nafziger, A.N. (1998) Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2 and xanthine oxidase activity determined with caffeine phenotyping. Clin. Pharmacol. Ther., 63, 540-551.
21. Simpson, P.J. and Lucchesi, B.R. (1987) Free radicals and myocardial ischaemia and reperfusion injury. J. Lab. Clin. Med., 110, 13-30.
22. Naito, Y., Yoshikawa, T., Yoshida, N. and Kondo, M. (1998) Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig. Dis, Sci., 43, 30S-34S.
23. Roy, D., Kalyanaraman, B. and Liehr, J.G. (1991) Xanthine oxidase-catalyzed reduction of estrogen quinones to semiquinones and hydroquinones. Biochem. Pharmacol., 42, 1627-1631.
24. Chan, D.K.-C. and Hargrove, J.L. (1993) Effects of dietary protein on gene expression. In Berdanier, C.D. and Hargrove, J.L. (eds) Nutrition and Gene Expression. CRC Press, Boca Raton, FL, pp. 353-375.
25. Day, R.O., Miners, J., Birkett, D.J., Graham, G.G. and Whitehead, A. (1988) Relationship between plasma oxypurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol. Br. J. Pharmacol., 26, 429-434.
26. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
27. Chen, C., Madeline, M.M., Lubinski, C., Weiss, N.S., Tickman, E.W. and Daling, J.R. (1996) Glutathione S-trasferase M1 genotypes and the risk of anal cancer: a population-based case control study. Cancer Epidemiol. Biomarkers Prev., 5, 985-991.
28. Arand, M., Muhlbauer, R., Hengstler, J., Jager, E., Fuchs, J., Winkler, L. and Oesch, F. (1996) A multiple polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem., 236, 184-186.
29. Jones, B. and Kenward, M.G. (1989) Design and Analysis of Cross-Over Trials. Chapman and Hall, London, UK.
30. Zeman, F.J. (1983) Clinical Nutrition and Dietetics. Macmillan, New York, NY.
31. Nakajima, M., Yokoi, T., Mizutani, M., Shin, S., Kadlubar, F.F. and Kamataki, T. (1994) Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol. Biomarkers Prev., 3, 413-421.
32. Campbell, M.E., Spielberg, S.P. and Kalow, W. (1987) A urinary metabolite ratio that reflects systemic caffeine clearance. Clin. Pharmacol. Ther., 42, 157-165.
33. Grant, D.M., Tang, B.K. and Kalow, W. (1983) Variability in caffeine metabolism. Clin. Pharmacol. Ther., 33, 591-602.
34. Kadlubar, F.F. Talaska, G., Butler, M.A., Teitel, C.H., Massengill, J.P. and Lang, N.P. (1990) Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites. In Mendelsohn, M.L. and Albertini, R.J. (eds) Mutation and the Environment. Part B: Metabolism, Testing Methods and Chromosomes. John Wiley, New York, NY, pp. 107-114.
35. Rostami-Hodjegan, A., Nurminen, S., Jackson, P.R. and Tucker, G.T. (1996) Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment. Pharmacogenetics, 6, 121-149.
36. Laird, N.M., Skinner, J. and Kenward, M. (1992) An analysis of two-period crossover designs with carry-over effects. Stat. Med., 11, 1967-1979.
37. Venables, W.N. and Ripley, B.D. (1994) Modern Applied Statistics with S-Plus. Springer, New York, NY.
38. Pantuck, E.J., Pantuck, C.B., Garland, W.A., Min, B.H., Wattenberg, L.W., Anderson, K.E., Kappas, A. and Conney, A.H. (1979) Stimulatory effect of Brussels sprouts and cabbage on human drug metabolism. Clin. Pharmacol. Ther., 25, 88-95.
39. Bonnesen, C., Stephensen, P.U., Andersen, O., Sørensen, H. and Vang, O. (1999) Modulation of cytochrome P-450 and glutathione S-transferase isoform expression in vivo by intact and degraded indolyl glucosinolates. Nutr. Cancer, 33, 178-187.
40. Beier, R.C. and Nigg, H.N. (1992) Natural toxicants in foods. In Nigg, H. and Seigler, D. (eds) Phytochemical Resources for Medicine and Agriculture. Plenum Press, New York, NY, pp. 247-367.
41. Koenigs, L.L. and Trager, W.F. (1998) Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins. Biochemistry, 37, 13184-13193.
42. Fukuda, K., Ohta, T., Oshima, Y., Ohashi, N., Yoshikawa, M. and Yamazoe, Y. (1997) Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics, 7, 391-396.
43. Schmiedlin-Ren, P., Edwards, D.J., Fitzsimmons, M.E., He.K., Lown, K.S., Woster, P.M., Rahman, A., Thummel, K.E., Fisher, J.M., Hollenberg, P.F. and Watkins, P.B. (1997) Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab. Dispos., 25, 1228-1233.
44. Bendriss, E.K., Bechtel, Y., Bendriss, A., Humbert, P.H., Paintaud, G., Magnette, J., Agache, P. and Bechtel, P.R. (1996) Inhibition of caffeine metabolism by 5-methoxypsoralen in patients with psoriasis. Br. J. Clin. Pharmacol., 41, 421-424.
45. Gradelet, S., Astorg, P., Leclerc, J., Chevalier, J., Vernevaut, M.F. and Siess, M.H. (1996) Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica, 26, 49-63.
46. Jewell, C. and O'Brien, N.M. (1999) Effect of dietary supplementation with carotenoids on xenbiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br. J. Nutr., 81, 235-242.
47. Campbell, D.R., Gross, M.D., Martini, M.C., Grandits, G.A., Slavin, J.L. and Potter, J.D. (1994) Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol. Biomarkers Prev., 3, 493-500.
48. MacLeod, S., Sinha, R., Kadlubar, F.F. and Lang, N.P. (1997) Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2. Mutat. Res., 376, 135-142.
49. Graham, T.E. and McLean, C. (1999) Gender differences in the metabolic responses to caffeine. In Tarnopolsky, M. (ed.) Gender Differences in Metabolism: Practical and Nutritional Implications. CRC Press, Boca Raton, FL, pp. 301-327.
50. Guerciolini, R., Szumlanksi, C. and Weinshilboum, R.M. (1991) Human liver xanthine oxidase: nature and extent of individual variation. Clin. Pharmacol. Ther., 50, 663-672.